izpis_h1_title_alt

Perinatal derivatives : how to best characterize their multimodal functions in vitro. Part C : Inflammation, angiogenesis, and wound healing
ID Flores, Ana I. (Avtor), ID Dragin Jerman, Urška (Avtor), ID Liarte, Sergio (Avtor), ID Erdani-Kreft, Mateja (Avtor), ID Tratnjek, Larisa (Avtor), ID Eissner, Günther (Avtor), et al.

.pdfPDF - Predstavitvena datoteka, prenos (1,38 MB)
MD5: BDB21374095E39089EE73A6B3B4F3932
URLURL - Izvorni URL, za dostop obiščite https://www.frontiersin.org/articles/10.3389/fbioe.2022.965006/full Povezava se odpre v novem oknu

Izvleček
Perinatal derivatives (PnD) are birth-associated tissues, such as placenta, umbilical cord, amniotic and chorionic membrane, and thereof-derived cells as well as secretomes. PnD play an increasing therapeutic role with beneficial effects on the treatment of various diseases. The aim of this review is to elucidate the modes of action of non-hematopoietic PnD on inflammation, angiogenesis and wound healing. We describe the source and type of PnD with a special focus on their effects on inflammation and immune response, on vascular function as well as on cutaneous and oral wound healing, which is a complex process that comprises hemostasis, inflammation, proliferation (including epithelialization, angiogenesis), and remodeling. We further evaluate the different in vitro assays currently used for assessing selected functional and therapeutic PnD properties. This review is a joint effort from the COST SPRINT Action (CA17116) with the intention to promote PnD into the clinics. It is part of a quadrinomial series on functional assays for validation of PnD, spanning biological functions, such as immunomodulation, anti-microbial/anti-cancer activities, anti-inflammation, wound healing, angiogenesis, and regeneration.

Jezik:Angleški jezik
Ključne besede:perinatal derivatives, therapeutic role, immunomodulation, mesenchymal stromal cells, amniotic epithelial cells, amniotic membrane, functional assays, inflammation, angiogenesis, wound healing
Vrsta gradiva:Članek v reviji
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2022
Št. strani:20 str.
Številčenje:Vol. 10, art. 965006
PID:20.500.12556/RUL-145368 Povezava se odpre v novem oknu
UDK:615.82/.84
ISSN pri članku:2296-4185
DOI:10.3389/fbioe.2022.965006 Povezava se odpre v novem oknu
COBISS.SI-ID:117424899 Povezava se odpre v novem oknu
Datum objave v RUL:19.04.2023
Število ogledov:368
Število prenosov:63
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Frontiers in bioengineering and biotechnology
Skrajšan naslov:Front. bioeng. biotechnol.
Založnik:Frontiers Media
ISSN:2296-4185
COBISS.SI-ID:523093017 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:perinatalni derivati​​, terapevtska vloga, imunomodulacija

Projekti

Financer:Drugi - Drug financer ali več financerjev
Program financ.:COST
Številka projekta:CA17116
Naslov:International Network for Translating Research on Perinatal Derivatives into Therapeutic Approaches
Akronim:SPRINT

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Instituto de Salud Carlos III

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Ministry of Economy, Industry, and Competitiveness

Financer:EC - European Commission
Program financ.:European Regional Development Fund
Številka projekta:PI18/01278

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:J7-2594
Naslov:Uporaba amnijske membrane za inovativno multimodalno zdravljenje bakterijskega cistitisa in raka sečnega mehurja: učinek njene protimikrobne, imunomodulatorne in protirakave aktivnosti

Financer:Drugi - Drug financer ali več financerjev
Program financ.:PON-MISE, Sustainable Growth Funding
Številka projekta:557

Financer:Drugi - Drug financer ali več financerjev
Program financ.:MIUR - PON, Attraction and International Mobility, Attrazione dei ricercatori, profilo 2.1

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Ministero della Sanità, Programma di Ricerca Finalizzata
Številka projekta:GR-2019-12369702

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj